Andy Ramelmeier, Ph.D.

Chief Technology Officer

Adverum Biotechnologies, A wholly-owned subsidiary of Eli Lilly and Company.

NA Summits

Medical Device
Manufacturing
Biomanufacturing
Aerospace & Defense
Automotive
Supply Chain
Pharma Manufacturing & Outsourcing
Packaging
CIO & Cybersecurity
Food Manufacturing
Electronics & High-Tech

EU Summits

Biomanufacturing
Manufacturing
Supply Chain
Pharma Manufacturing & Outsourcing
Medical Device
Food Manufacturing
Aerospace & Defence

Company

Homepage
About

Copyright © 2026